Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Sartorius Stedim Biotech Extends Portfolio with Majority Stake in AllPure Technologies

By BiotechDaily International staff writers
Posted on 04 May 2014
Sartorius Stedim Biotech (SSB; Aubagne, France) has signed a contract to acquire the majority stake in the privately owned start-up AllPure Technologies LLC (New Oxford, PA, USA). AllPure Technologies designs, manufactures, and markets innovative aseptic sampling and tube sealing systems for biopharmaceutical and pharmaceutical drug developers and manufacturers; it has been on the market for 4 years, and in 2013 earned revenue of around USD 3 million, with 25 employees. SSB, dedicated to a philosophy of “turning science into solutions,” is a leading global R&D company and provider of cutting-edge equipment, products, and services for the pharmaceutical and biotech industries; it employs approx. 3,300 people, and in 2013 earned sales revenue of EUR 588.4 million.

The takeover extends SSB's portfolio for single-use bioprocessing as AllPure specializes in innovative single-use components for biopharmaceutical applications, such as aseptic sampling techniques. AllPure has launched advanced products to improve operating efficiencies, process reliability, and operator safety. Supported by numerous patent-pending technologies, its products provide quick, reliable, and safe solutions to the shortcomings of current aseptic sampling techniques. AllPure operates in a state-of-the-art facility, and complies with applicable cGMP guidelines.

“AllPure further completes our portfolio with innovative products that help our customers develop and manufacture their pharmaceutical drugs safer and more efficiently. I am really looking forward to working with the AllPure team and to all that we can accomplish together,” said Reinhard Vogt, member of SSB’s Executive Board. "We are excited to leverage Sartorius Stedim’s impressive R&D capabilities so that we can accelerate the launch of new products from AllPure. And SSB’s global reach and industry relationships grant access to considerably more customers, especially in Europe and Asia, which have tremendous potential for AllPure’s products,” said Michael Zumbrum, President of AllPure. SSB and AllPure agreed not to disclose further details of the purchase agreement.

Related Links:

Sartorius Stedim Biotech 
AllPure Technologies 



WATERS CORPORATION

Channels

Genomics/Proteomics

view channel
Image: Electron micrograph of Hepatitis C virus purified from cell culture. Scale bar is 50 nanometers (Photo courtesy of the Center for the Study of Hepatitis C, the Rockefeller University).

Oxidized LDL Predicts Response to Interferon Treatment of Chronic Hepatitis C and May Be a Treatment Option

Oxidized low-density lipoprotein (oxLDL) in the blood was shown to predict responsiveness to interferon treatment in patients with chronic Hepatitis C virus (HCV) infection and to inhibit spread of the... Read more

Drug Discovery

view channel
Image: Molecular model of the anti-cancer drug 5-fluorouracil (Photo courtesy of Wikimedia Commons).

Novel Microcapsule Approach Reduces Toxic Side Effects of Chemotherapy

Cancer researchers have reduced chemotherapy's toxic side effects by using nanoporous capsules to transport an enzyme to the site of a tumor where it is activated by a selective heating process to convert... Read more

Lab Technologies

view channel
Image: The gene assembly robot, the GeneTheatre (Photo courtesy of Analytik Jena AG).

Genomic Research Laboratories Await New Compact Liquid Handling System

A small footprint benchtop liquid handler that automates multiple gene assembly tasks and associated procedures such as PCR setup is now available for use by biotech and genomic research laboratories.... Read more
 

Events

02 Jun 2015 - 03 Jun 2015
15 Jun 2015 - 18 Jun 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.